BNVI.F Stock Overview
Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Binovi Technologies Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.000001 |
| 52 Week High | CA$0.005 |
| 52 Week Low | CA$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BNVI.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 7.9% | 1.6% |
| 1Y | 0% | 16.0% | 32.3% |
Return vs Industry: BNVI.F underperformed the US Healthcare Services industry which returned 14.5% over the past year.
Return vs Market: BNVI.F underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| BNVI.F volatility | |
|---|---|
| BNVI.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BNVI.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine BNVI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jay Dhaliwal | n/a |
Binovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company’s products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete’s vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company’s products under development includes Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals.
Binovi Technologies Corp. Fundamentals Summary
| BNVI.F fundamental statistics | |
|---|---|
| Market cap | US$1.61m |
| Earnings (TTM) | -US$16.38m |
| Revenue (TTM) | US$186.35k |
0.0x
P/S Ratio0.0x
P/E RatioIs BNVI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BNVI.F income statement (TTM) | |
|---|---|
| Revenue | CA$186.35k |
| Cost of Revenue | CA$280.59k |
| Gross Profit | -CA$94.25k |
| Other Expenses | CA$16.29m |
| Earnings | -CA$16.38m |
Last Reported Earnings
Feb 28, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BNVI.F perform over the long term?
See historical performance and comparison